# Assessment of Efficacy of Zoledronic Acid in the Treatment of Bone Marrow Edema Syndrome

> **NCT01348269** · PHASE3 · COMPLETED · sponsor: **Wuerzburg University Hospital** · enrollment: 48 (actual)

## Conditions studied

- Bone Marrow Edema

## Interventions

- **DRUG:** Aclasta
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01348269
- **Lead sponsor:** Wuerzburg University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-05
- **Primary completion:** 2015-08-26
- **Final completion:** 2015-08-26
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2024-08-13

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01348269

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01348269, "Assessment of Efficacy of Zoledronic Acid in the Treatment of Bone Marrow Edema Syndrome". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01348269. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*